| Act | Activity |
| AD | applicability domain |
| AUC | Areas Under the Curve |
| BZN | benznidazole |
| CD | Chagas disease |
| CA | cluster analyses |
| CV | cyclic voltammetry |
| DNDi | Drugs for Neglected Diseases initiative |
| EPR | electron paramagnetic resonance |
| ESR | Electron Spin Resonance |
| HMDE | hanging mercury drop electrode |
| HOMO | highest occupied molecular orbital |
| IC50 | half-maximal inhibitory concentration |
| k-NNCA | k nearest-neighbor cluster analysis |
| k-MCA | k-means cluster analysis |
| LUMO | lowest unoccupied molecular orbital |
| NFX | nifurtimox |
| PS | prediction set |
| QSARs | quantitative structure–activity relationships |
| RF | Random Forest |
| ROS | reactive oxygen species |
| ROC | Receiver Operating Characteristic |
| SHAP | Shapley Additive Explanations |
| SD | standard deviation |
| TS | training set |
| TcNTRs | T. cruzi nitroreductases |